EXHIBIT 10.51 CORVAS INTERNATIONAL, INC. 401(K) COMPENSATION DEFERRAL SAVINGS PLAN AND TRUST AGREEMENT AMENDED AND RESTATED AS OF JANUARY 1, 1997Corvas International Inc • August 14th, 2002 • Pharmaceutical preparations • California
EXHIBIT 10.50 [Pfizer letterhead] John L. LaMattina, Ph.D. Vice President, Pfizer Inc Executive Vice President, PGRD President, Worldwide Research June 13, 2002 George Vlasuk Corvas International Inc. 3030 Science Park Road San Diego, California...Corvas International Inc • August 14th, 2002 • Pharmaceutical preparations
In accordance with Section 18.4 of the License and Development Agreement, dated October 14, 1995 between Corvas International, Inc. and Pfizer Inc, including Pfizer Limited (the " 1995 Agreement"), Pfizer has terminated the development in all indications of Neutrophil Inhibitory Factor and terminates the 1995 Agreement.
